Tag: Amneal Pharmaceuticals

Amneal launches generic Invega
October 10, 2019 Off

Amneal launches generic Invega

By BusinessWire

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), has launched its generic version of Invega® (paliperidone) extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg.

FDA grants first approvals for generics of Lyrica
July 22, 2019 Off

FDA grants first approvals for generics of Lyrica

By Dino Mustafić

The FDA has granted first approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr. Reddy’s Laboratories, InvaGen Pharmaceuticals, MSN Laboratories Ltd., Rising Pharmaceuticals, Inc., Sciegen Pharmaceuticals Inc., and Teva Pharmaceuticals.